Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease by Eli L. Diamond, Omar Abdel-Wahab, Benjamin H. Durham, Ahmet Dogan, Neval Ozkaya, Lynn Brody, Maria Arcila, Christian Bowers, and Mark Fluchel Blood Volume 128(14):1896-1898 October 6, 2016 ©2016 by American Society of Hematology
Perinephric tissue. Perinephric tissue. Patient 1 with a CD68+ histiocytic infiltrate with admixed fibrosis (A). Axial T2-fluid attenuation inversion recovery MRI images demonstrate scattered lesions in the brainstem and cerebellar peduncles (yellow arrows) (B), and these are resolved after 6 months of treatment (C). A representative FDG-avid (SUV 3.1) periarterial lesion (D, upper) has resolved to background uptake (D, lower). Sclerotic lesions from the distal femur of patient 2 (E). Expansile meningeal infiltrations are demonstrated by axial postgadolinium T1-weighted MRI scan (red arrow) before treatment (F) and then are resolved 2 years into anakinra therapy (G). Eli L. Diamond et al. Blood 2016;128:1896-1898 ©2016 by American Society of Hematology